Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by schemehatcheron Jan 22, 2014 11:54pm
292 Views
Post# 22123600

Looks like the Yanks are getting 1st crack....

Looks like the Yanks are getting 1st crack....
This gentlman ( copy below ) is doing a fine job on the US side, note the opp for a sneak peek.  Really excited about our opportunity.  Exercised warrants add strength to the bank account ( 8M now + 15M )  I am hoping that we follow the Novadaq path.  I owned this at 1.40 and sold well short of $2, ouch.  They moved their SP to $3 or $4 and listed in the US...Just shy of $22 now.  Their float is a 1/3 of ours.  A continuation of the trial will allow a move to a major exchange, we are largely ignored because of our cap size, and the US OTC listing.  I  believe only true followers have been buying, a NASDAQ listing would  move our SP.  A strong FDA report would give Wedbush the confidence in making the report widely available.  Cormark are "institutional support focussed", why would they write a lengthy report on a stock none of their clients could buy ?  This has to see $3 or $4 before big money gets interested, the interim could put us there, and the subsequent promotion and final approval could double that number - IMHO


Fun times after MANY years of holding, now i know how Sqr feels.

Schemer...see below

 
From: Sultan of 37
 
LOL.. Either I will be a hero or zero.. No middle ground when you invest in Biotech running trials.. End result is like you are in a Colosseum in Rome.. Thumb Up or Down.. Incidentally, it looks like the blog in question has been deleted.. I have no idea why or how that happened..

By the way, Wedbush Securities has a research report on Spectral Diagnostics so if you want it, do a PM to me..
Bullboard Posts